Phesgo compendium
WebMay 2, 2024 · Phesgo has different dosage and administration instructions than intravenous pertuzumab, intravenous trastuzumab, and subcutaneous trastuzumab when … WebJun 29, 2024 · Phesgo is a new fixed-dose subcutaneous (SC) formulation that combines Perjeta and Herceptin with Halozyme Therapeutics’ Enhanze® drug delivery technology. [1] This is the first time that Roche...
Phesgo compendium
Did you know?
WebMar 2, 2024 · Phesgo is indicated for use in combination with docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer, who have … WebPHESGO for anaphylaxis, angioedema, interstitial pneumonitis, or acute respiratory distress syndrome. Monitor patients until symptoms completely resolve [see Warnings and …
WebJun 29, 2024 · Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). WebMar 25, 2024 · This Phase III, randomized, two-arm, open-label, multicenter study will evaluate the efficacy and safety of giredestrant plus Phesgo compared with Phesgo after induction therapy with Phesgo plus taxane in participants with human epidermal growth factor receptor 2 (HER2)-positive, estrogen receptor (ER)-positive advanced breast cancer …
WebMar 1, 2024 · Phesgo (600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase per 10 mL) single-dose vial: 50242-0260-xx VII. References 1. Phesgo … Web1. Phesgo [package insert]. South San Francisco, CA; Genentech, Inc; June 2024. Accessed January 2024. 2. Referenced with permission from the NCCN Drugs & Biologics Compendium (NCCN Compendium®) pertuzumab, trastuzumab and hyaluronidase human. National Comprehensive Cancer Network, 2024. The NCCN Compendium® is a derivative …
WebNov 1, 2024 · Phesgo is indicated for use in combination with docetaxel for the treatment of adult patients with HER2-positive metastatic breast cancer who have not received prior …
WebPHESGO ® (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medicine approved for use in combination with chemotherapy for: use prior to surgery (neoadjuvant treatment) in adults with HER2-positive, locally advanced, inflammatory, or early stage breast cancer (tumor is greater than 2 cm in diameter or node-positive). green river the songWebSyringe storage 1. If the syringe containing PHESGO is not used immediately, it can be stored in the refrigerator for up to 24 hours (2°C to 8°C, 36°F to 46°F) and at room … flywheel puller toolflywheel puller princess autoWebPHESGO is contraindicated in patients with known hypersensitivity to pertuzumab, or trastuzumab, or hyaluronidase, or to any of its excipients. Additional Important Safety … flywheel puller tool harbor freightWebJun 29, 2024 · Phesgo is initially used in combination with chemotherapy and could continue to be administered at home by a qualified health care professional once the … flywheel puller tool for lawn mowerWebThis is a summary of the risk-management plan (RMP) for Phesgo (pertuzumab and trastuzumab fixed dose combination for subcutaneous injection). The RMP details important risks of Phesgo, how these risks can be minimized, and how more information will be obtained about Phesgo’s risks and uncertainties (missing information). green river tiny homesWebPHESGO is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the body (metastatic) and who have not received anti-HER2 therapy or chemotherapy for metastatic breast cancer. What are the most serious side effects of PHESGO? flywheel punch press